Antiemetics: Technologies and Global Markets
Report Highlights
The global market for antiemetics was nearly $2.4 billion in 2009. There was a little setback seen in 2009 in the 5-HT3 category due to weakened economy and competition within brands and generics. The market for antiemetic products is expected to reach $2.5 billion by the end of 2010 and $3.6 billion by 2015, reflecting a 7.4% compound annual growth rate (CAGR).
SCOPE OF THE STUDY
The scope of this study encompasses the biotechnology, pharmaceutical, and medical markets. BCC analyzes each market and its applications by its need for development of new medications, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
ABOUT THE AUTHOR
Shalini S. Dewan holds a master’s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are MST034C Reagents for Chromatography; IAS004B Spectroscopy, An Enduring Market; PHM006G Advanced Drug Delivery Systems: New Developments, New Technologies; PHM040A Orthopedic Drugs, Implants and Devices; HLC040C Medical Imaging Reagents and Analysis Equipment; PHM047A Pharmaceutical Regulatory Industry; and BIO014F The Dynamic Media, Sera and Reagent Market in Biotechnology.